Catalyst Pharmaceuticals
CPRX
$14.96
Share price
1.89%
Change (1 day)
-7.04%
Change (1 year)
Categories
P/S ratio for Catalyst Pharmaceuticals (CPRX)
P/S ratio as of April 2024 (TTM): 4.44
According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.44241. At the end of 2023 the company had a P/S ratio of 4.50.
P/S ratio history for Catalyst Pharmaceuticals from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.50 | -50.2% |
| 2022 | 9.04 | 82.53% |
| 2021 | 4.95 | 70.08% |
| 2020 | 2.91 | -23.19% |
| 2019 | 3.79 | -99.04% |
| 2018 | 395 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | 39.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | -14.60% | 🇺🇸 USA |
 Pfizer PFE | 2.45 | -44.74% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.65 | 4.56% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | 9.86 | 121.93% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0070 | -99.84% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 6.42 | 44.43% | 🇺🇸 USA |